Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

September 15, 2003
          The Company’s Bylaws were amended on September 15, 2003 by the adoption of the following resolution by the Board of Directors:
    RESOLVED, that the first sentence of Section 1 of the By-laws of the Company be, and hereby is, amended to read in its entirety as follows:
 
    “The number of directors who shall constitute the whole Board of Directors shall be such number as the Board of Directors shall from time to time have designated, except that in the absence of any such designation, such number shall be three (3).”